Introduction
Experimental autoimmune encephalomyelitis (EAE) is an animal model of multiple sclerosis (MS) that is induced by active immunization against myelin antigens in genetically susceptible mice strains and reproduces the immunopathology seen in many MS cases (Swanborg 1995) . Several days after immunization, immune cells start to infiltrate the CNS and microglial cells are activated, predominantly affecting the spinal cord but also other brain structures like the cerebellum and the optic tract (Brown and Sawchenko 2007) . This is followed by axonal damage and demyelination (Soulika et al., 2009) .
The EAE mouse model is characterized by T-and B-cell responses to myelin oligodendrocyte glycoprotein (Iglesias et al., 2001) . Depending on the composition of the inflammatory environment, differentiation of T-helper (Th)-cells is directed towards effector or regulatory T-cells. Several groups have addressed the involvement of Th17-positive cells as autoimmune effectors in EAE and of (Foxp3) + cells as regulatory T-cells (for review see (Korn et al., 2007; Langrish et al., 2005) . Cytokines like transforming growth factor beta (TGF-β) and interleukin-6 (IL-6) are known to affect the course of differentiating T-cells (Fallarino et al., 2010; Tzartos et al., 2008) .
Pharmacological manipulation of cAMP levels using specific PDE4 inhibitors provoke profound anti-inflammatory responses (Nielson et al., 1990; Torphy 1998) , for example, suppression or stimulation of cytokine production (Jin and Conti 2002; Sommer et al., 1995) , and inhibition of T-cell proliferation (Banner and Trevethick 2004) . In the EAE model, amelioration of the clinical signs and delayed onset is observed after PDE4 inhibition with rolipram (Folcik et al., 1999; Moore et al., 2006; Sommer et al., 1995) . The PDE4B gene has been related to the inflammatory response in mouse monocytes and macrophages (Jin et al., 2005a) and previous publications by our group have shown that the PDE4B mRNA splice variant PDE4B2 is upregulated in cellular infiltrates of EAE rat brains (Reyes-Irisarri et al., 2007) . Furthermore, during innate inflammation the expression of both PDE4B2 and PDE4B3 mRNAs are altered (Johansson et al., 2011; 2012b) , suggesting a possible role of these enzymes in regulating the cytokine environment during neuroinflammation.
The distinct cellular distribution of PDE4 subfamily mRNAs and their presence in the cellular infiltrates in the rat EAE model prompted us to further characterize their alterations and the cellular locations of the PDE4B enzyme during the course of EAE in mice. This information provides important aspects for the development of PDE4 specific inhibitors in order to treat MS and other inflammatory diseases.
Here we present the anatomical localization of changes in PDE4B and PDE4B splice variants expression along the course of EAE in mice spinal cord and brain. A specific upregulation of the PDE4B2 mRNA was detected from the spinal cord extending toward the rostral parts of the brainstem. In addition, we analyzed the presence of the PDE4B enzyme in different infiltrating cell populations. Correlation between cytokine transcription and the PDE4B2 mRNA was observed in a scoredependent manner. To further elucidate the role of PDE4 subfamilies during the neuroinflammatory response in the EAE model we performed an initial study with
PDE4A
-/-and PDE4B -/-mice.
Material and methods

Mice
Six-week-old female C57BL/6J mice (15-20 g) were purchased from Charles River Laboratories (Lyon, France). The generation of mice deficient in PDE4B and PDE4A has been described previously (Jin et al., 1999; Jin et al., 2005b; Jin and Conti 2002 
EAE induction and treatment
EAE was induced by subcutaneous immunization of female mice with 100μg MOG peptide (Sigma-Aldrich, Steinheim, Germany) in 100μl CFA (Sigma-Aldrich) enriched
with Mycobacterium tuberculosis (Difco, Detroit, MI, USA) on day 0, followed by 200ng of pertussis toxin injected intraperitoneally on days 0 and 2. "CFA control mice" received CFA and pertussis toxin, but no MOG 35-55 peptide.
Animals were weighed and examined daily and the severity of their clinical disease was graded using a five-point scale: Grade 0 = no disability; 1 = a flaccid tail; 2 = a mild but definite weakness of one or both hind legs; 3 = moderate paraparesis of one hind leg; 4 = no hind leg movement; 5 = a moribund state with little or no spontaneous movement and impaired respiration (McFarlin et al., 1974) . Clinical signs and score were monitored up to the day of the sacrifice. Six independent EAE groups were used in this study.
Tissue preparation
Brain and spinal cord were removed, rapidly frozen on dry ice and stored at -20 °C on p.i. days 10 (n=5), 15 (n=5), 21 (n=20) and 30 (n=8), CFA-injected control mice (n=6) and PDE4A-/-(n=4), PDE4B-/-(n=5), and wildtype control mice (n=4).
Hybridization probes and in situ hybridization histochemistry
For in situ hybridization, immunohistochemistry and histology, 14-μm thick coronal tissue sections of whole brain from EAE and CFA-control mice were cut on a microtome-cryostat (Microm HM500 OM, Walldorf, Germany), thaw-mounted on 3-aminopropyltriethoxysilane-coated slides (Sigma-Aldrich), and stored at -20 °C until further processing.
The oligonucleotides complementary to the mRNAs coding for the different PDEs have previously been described (Johansson et al., 2011) . Oligonucleotide labeling and in situ hybridization conditions used have been described elsewhere Tomiyama et al., 1997) . Hybridized sections were either exposed to Biomax-MR (Kodak, Rochester, NY, USA) or dipped into Ilford K5 nuclear emulsion (Ilfor, Mobberly, Cheshire, UK).
The specificity of the autoradiographic signal obtained by in situ hybridization histochemistry experiments was confirmed by performing a series of routine controls (Supplementary Figure 3 ) similar to those previously described (Pompeiano et al., 1992; Sanabra and Mengod 2011) . Furthermore, hybridization with a scramble oligonucleotide only produced background hybridization signal
Histology
Brain sections were stained with Luxol Fast Blue (LFB) and cresyl violet for demyelinization and infiltrating cells.
Immunohistochemistry
The following antibodies were used: rabbit anti-human CD3 (Dako Cytomation, 
Quantitative RT/PCR
Total RNA extracted from frozen cervical spinal cords from EAE mice at days 10, 15, 21, and 30 and from CFA-injected control animals (1 g) was reverse-transcribed into cDNA using the iScript kit (Bio-Rad, Hercules, CA, USA). Gene transcripts were quantified by semiquantitative real-time RT-PCR using the iQ SYBR Green Supermix kit The n-fold differential expression was determined by the comparative cycle threshold (CT) method (2 -ΔΔ CT), normalized to the HPRT endogenous reference gene. Negative control experiments were performed without the addition of template cDNA. End reaction products were visualized using SYBRSafe (Invitrogen) in 3.4% agarose gels to verify the correct product sizes.
Lymphocyte stimulation and ELISA
In vitro stimulation responses of spleen cells were determined using a standard microtiter assay. Briefly, spleen cells isolated from EAE wt and KO mice 21 days p.i.
were cultured in 96-well, flat bottom tissue culture plates at 4x10 5 cells per well for 4h
in RPMI medium. Cells were then stimulated using 25 g of MOG 
Figure preparation
Photographs of the film autoradiograms of hybridized sections were obtained using a
Wild 420 macroscope (Leica, Heerbrugg, Germany) equipped with a digital camera (DXM1200 F, Nikon, Tokyo, Japan) and ACT-1 Nikon software. Microphotographs of the hybridized tissue slides were taken with a Zeiss Axioplan microscope, equipped with a digital camera (DXM1200 F, Nikon) with ACT-1 Nikon software and a Darklite illuminator (Micro Video Instruments, Avon, MA, USA) to improve the visualization of autoradiographic silver grains and capture bright-and dark-field images. Double immunofluorescent-labeled sections were photographed in an Olympus BX51 stereo microscope equipped with a digital camera (DP71, Olympus, Tokyo, Japan). The figures were assembled using Adobe Photoshop (Adobe Systems, San Jose, CA, USA); only contrast and brightness were adjusted to optimize the images.
Analysis of the results
Statistical comparisons between EAE and control mice were carried out by separate one-way ANOVA followed by post-hoc analysis Bonferroni's test for day post injection.
Statistical comparisons using the factors day post-immunization or, using the factors inflammatory markers and immunization were carried out by separate two-way ANOVA followed by post-hoc Dunnett's test for day post-immunization and clinical score by post-hoc Tukey's test for inflammatory marker and mice used respectively.
The correlation analysis was performed by Pearson's correlation method. All statistical analyses were performed in GraphPad Prism 4 (GraphPad Software, San Diego, CA). (Fig 1A, B) and DAPI (Fig.   1C ). Observations with SMI-32 ( Fig 1D) and FluoroJadeB ( Fig 1E) also confirmed the presence of axonal damage and neurodegeneration in our EAE model.
Results
The chronic model of EAE in C57BL/
PDE4 mRNA expression in the central nervous system of mice with EAE
We studied the mRNA expression of the three PDE4 subfamilies, PDE4A, PDE4B and PDE4D in EAE mouse brainstem and cerebellum (Fig2A-F). PDE4B and PDE4D mRNAs are normally present at high levels in the granular layer of the cerebellum of CFA control mice (Fig. 2H, 2I ) (Johansson et al., 2012a) . PDE4B mRNA showed overexpression in EAE mice in a patchy-like manner (Fig. 2B , E, white arrow heads), whereas the other two subfamilies presented an unchanged hybridization pattern with the disease. We further analyzed the four PDE4B splice variants mRNA expression in these animals and observed that the only mRNA upregulated was PDE4B2 (Fig. 2K, O) in EAE brain sections, showing a similar pattern to that observed for PDE4B mRNA ( Fig.   2B , E).
The anatomical localization of PDE4B2 mRNA in the brainstem and spinal cord of EAE mice with established disease, i.e. 30 days p.i., was further determined. The upregulation of PDE4B2 mRNA expression is visible as dark patches of autoradiographic grains following radioactive in situ hybridization histochemistry at several levels of the brainstem of the EAE mouse ( Fig. 3A-C) , whereas in CFA-treated control mice no alterations in the hybridization signal were observed ( Fig. 3D-F) .
We evaluated the mRNA expression levels of the PDE4B2 splice variant in mouse brain and spinal cord at different p.i. times (before the onset of EAE at day 10, just after the onset of disease at day 15, around the peak at day 21, and at day 30).
The results obtained in spinal cord sections of EAE and CFA-injected control mice using semiquantitative real-time RT-PCR revealed upregulation of PDE4B2 mRNA expression that increased with the time after immunization, being statistically significant in animals at 30 days p.i. (Fig. 3G) . We also observed a significant PDE4B2 mRNA upregulation with increasing disease scores at day 30 p.i. (Fig. 3G) . Changes in various inflammatory markers (tumor necrosis factor -α (TNF-α), IL-6, FoxP3, IL-17, interferon-γ (IFN-γ), IL-1β and TGF-β) were also investigated with semiquantitative real-time RT-PCR to validate the immune response. All markers were upregulated at day 15 (except IFN-γ and IL-6) and at day 21 (data not shown).
PDE4B protein expression in the central nervous system of mice with EAE
In order to determine whether PDE4B2 mRNA upregulation in the EAE mice corresponded to an increase in the amount of synthesized protein we incubated tissue sections with an antibody against PDE4B and compared them to consecutive spinal cord sections hybridized for PDE4B2 mRNA (Fig. 3H) (Fig. 4) . We observed that microglia/macrophages (Fig. 4 A-F ) and dendritic cells ( ( Fig. 4J-L) ; however, polarization of PDE4B at the contact area between these two cells could be detected (inset Fig. 4L ). In areas with cell infiltrates oligodendrocytes were clearly absent, indicating demyelination (see Supplementary Figure 2 ). PDE4B protein was not observed in infiltrating neutrophiles (see Supplementary Figure 2C ).
Nevertheless, PDE4B expression could be detected at low intensity in some oligodendrocytes and astrocytes (see Supplementary Figure 2F , I), which might be explained by the expression of PDE4B3 splice variant in these cells (Johansson et al., 2011) .
The chronic model of EAE in PDE4A -/-and PDE4B -/-mice: EAE progression and neuroinflammatory response
In order to further examine the role of PDE4 enzymes in EAE, we immunized PDE4A
-/-and PDE4B -/-mice. Our preliminary results show an earlier onset of the disease for PDE4B -/-mice and a trend to lower clinical score for the PDE4A -/-mice group compared to wt. PDE4B -/-mice start to show neurological deficits around day 10 p.i., reaching a maximum at day 14 p.i. (Fig. 5A ).
The expression levels for several inflammatory cytokines and for some transcription factors (markers of different T-cell subsets) were determined to evaluate the inflammatory response. In the PDE4A -/-mice group a significant decrease in mRNA expression for TNF- and IFN- was observed compared to the wt group (Fig. 5B) . We also detected a significant downregulation of Rorc transcription factor mRNA expression in PDE4A -/-mice (Fig. 5C ). The PDE4B -/-group showed a significant decrease in mRNA expression of TGF- and Rorc (Fig. 5C ). Furthermore, a tendency to downregulation of IFN- and TNF- mRNA expression and a trend to upregulation of the proinflammatory cytokine IL-6 (Fig. 5B) were observed in the PDE4B -/-mice.
The immunological response capacity of leukocytes from knockout mice was measured by in vitro stimulation. Compared to wt, no changes in IL-4 production after MOG stimulation could be detected at any time point. However, lower levels of IFN- production in PDE4B -/-leukocytes were seen, whereas PDE4A -/-splenocytes seemed to produce similar levels as the wt group (data not shown).
Evaluation of axonal degeneration showed no differences in SMI32 immunoreactivity in spinal cord tissue sections of knockout and wt mice (data not shown).
PDE4B2 splice variant in disease severity and cytokine expression
In view of the results obtained with PDE4B -/-mice in disease severity and differences in cytokine expression, we analyzed the correlation between PDE4B2 mRNA and inflammatory cytokines or T cell specific transcription factors in our EAE mice at the peak of the disease, day 21 after immunization. The mRNA levels for PDE4B2 correlated significantly (Pearson correlation, R= 0.927; P< 0.05) with clinical scores (Fig.   6A ). The relative mRNA expression of PDE4B2 also revealed statistically significant correlations (Pearson correlation) with FoxP3 (R= 0.71; P< 0.001) (Fig. 6B ) and with TGF- (R= 0.64; P< 0.005) (Fig. 6C) . No correlation was found with other inflammatory markers such as TNF, IL-17 and IL-6 (data not shown).
Discussion
The work presented here shows that the PDE4B subfamily and particularly the PDE4B2 (Jin et al., 2005a; Jin and Conti 2002) . In our group we have previously reported a selective increase in PDE4B2 mRNA levels in LPS-treated rats (Reyes-Irisarri et al., 2008) and in brain circumventricular organs of LPS-treated mice (Johansson et al., 2011) . All this together points to the involvement of the PDE4B subfamily in events related to neuroinflammation.
PDE4B2 mRNA expression is found in many brain areas in both rat (ReyesIrisarri et al., 2007) and mouse (Johansson et al., 2011) . Upregulation of PDE4B2 mRNA expression was observed 2-3 days after the onset of the disease (day 15), and was significantly elevated in animals with ongoing EAE in the spinal cord and later spreading throughout the posterior brain areas, coinciding with previous results in rats (Reyes-Irisarri et al., 2007) . The PDE4B protein presented a distribution pattern comparable to that observed for infiltrating cells in the EAE brain during disease (Brown and Sawchenko 2007) suggesting that these cells might express PDE4B2 at elevated levels. The correlation between PDE4B2 mRNA expression and the clinical score reported here further supports this assumption, since an advanced clinical score is associated with an elevated number of cellular infiltrates (Brown and Sawchenko 2007) . The increase in PDE4B protein expression, which coincides with the PDE4B2 mRNA upregulation in areas with high infiltration of immune cells and morphological damage and not in other brain areas, might be a reflection of a selective regulation of the enzyme to control cAMP levels. This exclusive PDE4B increment in the brain infiltrates could also be important for the local regulation of cytokine secretion and the antigen presentation process as explained below.
In the EAE model, peripheral antigen-presenting cells (APCs) like dendritic cells and macrophages associated with the meninges and CNS blood vessels (Greter et al., 2005; Sospedra and Martin 2005) are known to infiltrate the CNS where lymphocytes are reactivated by the main APC population in the brain parenchyma, microglia, as reviewed by Almolda and coworkers ( 2011) . Activation/suppression of APCs and regulation of the cytokine environment are known to be controlled by cAMP levels (Fassbender et al., 2010; Kambayashi et al., 2001) . Therefore the upregulation of PDE4B2 mRNA that we report here, in areas with high amount of cellular infiltrates and around the microvessels, together with the role of cAMP in the antigen presentation process (Fallarino et al., 2010) The amelioration of the clinical signs and delayed onset of EAE described after PDE4 inhibition (Folcik et al., 1999; Martinez et al., 1999; Moore et al., 2006; Sommer et al., 1995) T-cell populations that have a crucial role in the EAE model are Th1-and Th17-positive cells (Komiyama et al., 2006; Tzartos et al., 2008; Zamvil and Steinman 1990) . These immune cells infiltrate and attack oligodendrocytes, activate resident microglia and astrocytes, leading to demyelination and axonal damage in the EAE model (Lassmann et al., 2001; Soulika et al., 2009) . Another T-cell population, FoxP3 + Treg cells, regulates the immunological response e.g. by secretion of anti-inflammatory cytokines (Korn et al., 2007) . The conversion of T-cells into the more favorable Foxp3 + T-regs or the hazardous Th17 + -cells is dependent on the inflammatory environment where TGF-β and IL-6 play a role in the balance between these two cell populations (Deshpande et al., 2007; Fallarino et al., 2010; Korn et al., 2007) . The presence of both IL-6 and TGF-β induces Th17 differentiation from naïve T cells (Mangan et al., 2006) ; however, TGF-β alone has immunosupressor properties and can induce Tregs FoxP3+ cells generation (Li et al., 2006) .
In the PDE4B -/-mice spinal cord we observed a tendency for upregulation of IL-6 mRNA whereas TGF- mRNA is expressed at lower levels than in wt. This change in the balance between these two cytokines could result in higher Th17 cells differentiation producing the earlier onset of the disease in the PDE4B -/-mice. In fact, PDE4B -/-mice spleen cells seem to produce significant higher amounts of IL-17 after MOG stimulation in vitro (data not shown).
The correlation described between PDE4B2 mRNA upregulation and FoxP3+ and TGF-β expression in EAE mice, together with the lack of correlation with IL-6 opens new lines of investigation on the possible role of this PDE4B splice variant in Treg cells differentiation, possibly by modulating the cytokine environment. Changes in IL-6 production and TGF-β mRNA expression have been described in APCs such as microglia/macrophages following brain injury (Delfino and Walker 1999; Fallarino et al., 2010; Hashioka et al., 2007) , cells where we found an increase of PDE4B.
Conclusion
We have shown that in EAE mice a specific upregulation of the PDE4B2 splice variant mRNA takes place in a score and time-dependent manner, as a patchy pattern throughout the spinal cord and the brainstem. The PDE4B upregulation occurs mainly in antigen presenting cells in areas with high amounts of brain infiltrates where it might modulate cAMP levels and consequently the local cytokine secretion important for T-cell differentiation.
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